We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Pharmacovigilance – Products

App Note / Case Study

Achieve Sensitive Quantitation of GLP Analogs in Biological Matrices

Glucagon-like peptide-1 (GLP-1) analogs regulate systemic homeostasis, making them effective in the treatment of type 2 diabetes. However, their low bioavailability limits their detection and quantitation in biological matrices, causing challenges in drug development.
Techniques for Oligonucleotide Analysis

Techniques for Oligonucleotide Analysis

This article presents current techniques in oligonucleotide production and characterization, highlighting recent advancements that enhance the efficiency of these methods
Six faces in front of a DNA double helix.
Product News

Thermo Fisher Scientific Launches PangenomiX Array

Most comprehensive and ethnically diverse genomic coverage on a high throughput microarray delivers multi-disease and pharmacogenomic research analysis across global populations.
Heralding a New Era of RNA Therapeutics content piece image

Heralding a New Era of RNA Therapeutics

This article explores how scientists are tackling the challenges and intensifying efforts to develop mRNA therapeutics for different diseases.
A scientist holding a pipette.
Product News

SolasCure Demonstrates Proof-of-Concept in Phase Ila Safety Trial of Aurase Wound Gel

SOLASCURE Ltd, a biotechnology company developing a hydrogel containing tarumase (provisional INN), a recombinant enzyme derived from maggots, and which aims to accelerate wound debridement and contribute to wound bed preparation & healing.
Organ on a chip.
Product News

CN Bio PhysioMimix Organ-on-a-Chip Data Supports Inipharm’s INI-822 for Metabolic Liver Disease Treatment

PhysioMimix NASH assay used to provide human-relevant data on compound efficacy for Inipharm’s lead candidate, INI-822.
A lab worker pipetting a solution onto a plate.
Product News

FDA Grants Fast Track Designation to SonALAsense’s SONALA-001

Encouraging preliminary data from the ongoing DIPG clinical study to be presented at the 2023 Society for Neuro-Oncology Annual Meeting in Vancouver.
A worker in a lab.
Product News

Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria

Glox Therapeutics, announced it has raised £4.3M in seed funding to develop effective targeted therapeutics against antibiotic-resistant Gram-negative bacteria.
A scientist behind a screen.
Product News

Armis Biopharma Announces Receipt of a $20.3 Million Contract with the Defense Threat Reduction Agency to Develop Veriox® DECON for Battlefield Wounds

Armis Biopharma, Inc. announced that the company received a $20.3 million contract from the Defense Threat Reduction Agency (DTRA) to develop its proprietary Veriox® DECON chemical warfare agent (CWA) decontamination product.
A doctor holding a clipboard with a patient.
Product News

OncoHost To Present Proteomics-Based Predictive Biomarker for Immune-Related Adverse Events in NSCLC Patients

Novel computational model accurately predicts significant irAEs in NSCLC patients based on proteomic profiling of one pre-treatment blood test.